ZA200205567B - Quaternary ammonium and their use as anti-tussive agent. - Google Patents
Quaternary ammonium and their use as anti-tussive agent.Info
- Publication number
- ZA200205567B ZA200205567B ZA200205567A ZA200205567A ZA200205567B ZA 200205567 B ZA200205567 B ZA 200205567B ZA 200205567 A ZA200205567 A ZA 200205567A ZA 200205567 A ZA200205567 A ZA 200205567A ZA 200205567 B ZA200205567 B ZA 200205567B
- Authority
- ZA
- South Africa
- Prior art keywords
- quaternary ammonium
- sup
- tussive agent
- compounds
- tussive
- Prior art date
Links
- 239000003434 antitussive agent Substances 0.000 title 1
- 229940124584 antitussives Drugs 0.000 title 1
- 125000001453 quaternary ammonium group Chemical group 0.000 title 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2292343 | 1999-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200205567B true ZA200205567B (en) | 2003-10-13 |
Family
ID=4164883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200205567A ZA200205567B (en) | 1999-12-15 | 2002-07-11 | Quaternary ammonium and their use as anti-tussive agent. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20030181489A1 (cs) |
| EP (1) | EP1254104B1 (cs) |
| JP (1) | JP2003517034A (cs) |
| KR (1) | KR20020092352A (cs) |
| CN (1) | CN1423630A (cs) |
| AT (1) | ATE293097T1 (cs) |
| AU (1) | AU2334701A (cs) |
| BG (1) | BG106815A (cs) |
| BR (1) | BR0016427A (cs) |
| CZ (1) | CZ20022097A3 (cs) |
| DE (1) | DE60019465D1 (cs) |
| EE (1) | EE200200315A (cs) |
| HU (1) | HUP0203918A3 (cs) |
| IL (1) | IL150181A0 (cs) |
| IS (1) | IS6416A (cs) |
| MX (1) | MXPA02006049A (cs) |
| NO (1) | NO20022868L (cs) |
| NZ (1) | NZ519747A (cs) |
| PL (1) | PL355944A1 (cs) |
| RU (1) | RU2002116212A (cs) |
| WO (1) | WO2001044167A1 (cs) |
| ZA (1) | ZA200205567B (cs) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2703324A (en) * | 1950-08-30 | 1955-03-01 | Bristol Lab Inc | Basic ethers of aralkyl phenols and salts thereof |
| US2642434A (en) * | 1951-09-05 | 1953-06-16 | Sterling Drug Inc | Quaternary ammonium salts of lower alkyl 4-substituted-2-(tertiaryaminoalkoxy) benzoates and their preparation |
| US2913459A (en) * | 1954-12-09 | 1959-11-17 | Eprova Ltd | New quaternary ammonium compounds and process for the production thereof |
| GB919126A (en) * | 1958-07-01 | 1963-02-20 | Wellcome Found | Quaternary ammonium compounds and their preparation |
| GB935613A (en) * | 1960-02-04 | 1963-08-28 | Wellcome Found | Quaternary ammonium compounds and their preparation |
| US3840666A (en) * | 1972-07-05 | 1974-10-08 | Univ Michigan | Anti-arrhythmic quaternary salt compositions and methods of use |
| US4048335A (en) * | 1974-06-17 | 1977-09-13 | The Regents Of The University Of Michigan | Method of inhibiting myocardial ischemia in mammals using quaternary salts |
| DE2940765A1 (de) * | 1979-10-08 | 1981-04-23 | Basf Ag, 6700 Ludwigshafen | Substituierte alkylammoniumsalze, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer |
| BR9911095A (pt) * | 1998-06-09 | 2002-01-15 | Nortran Pharmaceuticals Inc | Compostos de amÈnios quartenário como agentes anti-tussìgenos |
-
2000
- 2000-12-15 PL PL00355944A patent/PL355944A1/xx not_active Application Discontinuation
- 2000-12-15 NZ NZ519747A patent/NZ519747A/xx unknown
- 2000-12-15 MX MXPA02006049A patent/MXPA02006049A/es unknown
- 2000-12-15 KR KR1020027007715A patent/KR20020092352A/ko not_active Withdrawn
- 2000-12-15 WO PCT/CA2000/001508 patent/WO2001044167A1/en active IP Right Grant
- 2000-12-15 CZ CZ20022097A patent/CZ20022097A3/cs unknown
- 2000-12-15 EP EP00986919A patent/EP1254104B1/en not_active Expired - Lifetime
- 2000-12-15 US US10/149,668 patent/US20030181489A1/en not_active Abandoned
- 2000-12-15 IL IL15018100A patent/IL150181A0/xx unknown
- 2000-12-15 DE DE60019465T patent/DE60019465D1/de not_active Expired - Lifetime
- 2000-12-15 JP JP2001545256A patent/JP2003517034A/ja active Pending
- 2000-12-15 AU AU23347/01A patent/AU2334701A/en not_active Abandoned
- 2000-12-15 HU HU0203918A patent/HUP0203918A3/hu unknown
- 2000-12-15 CN CN00818439A patent/CN1423630A/zh active Pending
- 2000-12-15 EE EEP200200315A patent/EE200200315A/xx unknown
- 2000-12-15 RU RU2002116212/14A patent/RU2002116212A/ru not_active Application Discontinuation
- 2000-12-15 AT AT00986919T patent/ATE293097T1/de not_active IP Right Cessation
- 2000-12-15 BR BR0016427-5A patent/BR0016427A/pt not_active IP Right Cessation
-
2002
- 2002-06-12 BG BG106815A patent/BG106815A/xx unknown
- 2002-06-12 IS IS6416A patent/IS6416A/is unknown
- 2002-06-14 NO NO20022868A patent/NO20022868L/no not_active Application Discontinuation
- 2002-07-11 ZA ZA200205567A patent/ZA200205567B/xx unknown
-
2005
- 2005-04-26 US US11/115,633 patent/US20050197383A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022868L (no) | 2002-08-14 |
| PL355944A1 (en) | 2004-05-31 |
| EP1254104B1 (en) | 2005-04-13 |
| JP2003517034A (ja) | 2003-05-20 |
| US20030181489A1 (en) | 2003-09-25 |
| IL150181A0 (en) | 2002-12-01 |
| EE200200315A (et) | 2003-08-15 |
| CZ20022097A3 (cs) | 2002-11-13 |
| NZ519747A (en) | 2003-08-29 |
| HUP0203918A2 (hu) | 2003-03-28 |
| EP1254104A1 (en) | 2002-11-06 |
| CN1423630A (zh) | 2003-06-11 |
| KR20020092352A (ko) | 2002-12-11 |
| WO2001044167A8 (en) | 2001-12-06 |
| RU2002116212A (ru) | 2004-02-10 |
| ATE293097T1 (de) | 2005-04-15 |
| MXPA02006049A (es) | 2004-08-23 |
| WO2001044167A1 (en) | 2001-06-21 |
| HUP0203918A3 (en) | 2005-06-28 |
| BR0016427A (pt) | 2002-10-29 |
| US20050197383A1 (en) | 2005-09-08 |
| DE60019465D1 (de) | 2005-05-19 |
| NO20022868D0 (no) | 2002-06-14 |
| AU2334701A (en) | 2001-06-25 |
| BG106815A (en) | 2003-04-30 |
| IS6416A (is) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| DE69529670D1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| GB0128996D0 (en) | Organic compounds | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| AU2002305143A1 (en) | Pyrazolo'1,5-a!pyridine derivatives | |
| MY140674A (en) | New crystalline form of a triazolo(4,5-d)pyrimidine compound | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| GB0012240D0 (en) | Therapeutic agents | |
| MXPA03002911A (es) | Compuestos quimicos. | |
| AU2001266575A1 (en) | Chemical compounds | |
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| YU44102A (sh) | Ciklična kvaternerna amonijum jedinjenja | |
| YU44202A (sh) | Kvaternerne soli n-substituisanih cikiličnih ili ne- cikličnih amina kao farmaceutski preparati | |
| AU2002359150A8 (en) | Therapeutic heterocycles | |
| TW252979B (cs) | ||
| ZA200205567B (en) | Quaternary ammonium and their use as anti-tussive agent. | |
| AU2149797A (en) | Therapeutic agents for asthma | |
| CA2353956A1 (en) | Remedial agent for erectile dysfunction | |
| PL1610785T3 (pl) | Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu |